BESREMi
@besremi.com
BESREMi is the only FDA-approved polycythemia vera (PV) treatment that targets the source of the disease. View important safety info, prescribing info, and boxed warning.
BESREMi's Company Logos
BESREMi's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#E2422A
Cinnabar
226, 66, 42
8, 76, 53
0, 71, 81, 11
#F8DFAA
Peach Yellow
248, 223, 170
41, 85, 82
0, 10, 31, 3
#2E4B58
Pickled Bluewood
46, 75, 88
199, 31, 26
48, 15, 0, 65
About BESREMi
PharmaEssentia is a pioneering healthcare company dedicated to improving the lives of patients with polycythemia vera (PV). Their flagship product, BESREMi® (ropeginterferon alfa-2b-njft), is the only FDA-approved treatment specifically targeting the underlying cause of PV in the bone marrow. This innovative therapy aims to provide measurable benefits to patients by addressing their unique medical needs.
PharmaEssentia's commitment extends beyond just medications. The company offers a wealth of resources to support both patients and healthcare professionals, including comprehensive prescribing information, safety guidance, and educational materials. Through the PharmaEssentia SOURCE platform, patients can access advocacy programs, financial assistance, and tools tailored to help navigate their treatment journey.
As a trusted partner in health, PharmaEssentia prioritizes patient safety and well-being, offering continuous support and information about BESREMi® to guide individuals throughout their treatment experience. Their goal is to ensure that every patient receives the attention and care they deserve.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Related Brands
Tags
Polycythemia vera treatment
Ropeginterferon alfa-2b-njft
Bone marrow targeted immunotherapy
Cytoreductive therapy
